The research time span covered by the report is from 2019 to 2030; it provides an overview of the Global Advanced Molecular Nuclear Imaging Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.

The global Advanced Molecular Nuclear Imaging market size in 2023 is 4777.9 million US dollars, and it is expected to be 6858.5 million US dollars by 2030, with a compound annual growth rate of 5.3% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Advanced Molecular Nuclear Imaging market include Cardinal Health, Jubilant Pharma Holdings Inc., Novartis AG, Siemens Healthcare GmbH, and Koninklijke Philips N.V.. The share of the top 3 players in the Advanced Molecular Nuclear Imaging market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Advanced Molecular Nuclear Imaging market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. SPECT Systems accounted for XX% of Advanced Molecular Nuclear Imaging market in 2023. Hybrid PET Systems share of XX%.
Oncology accounted for XX% of the Advanced Molecular Nuclear Imaging market in 2023. Cardiology accounts for XX%.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it”s going to evolve in the years to come.

Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, study objectives and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Advanced Molecular Nuclear Imaging market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapters 3-5: Segmented the global Advanced Molecular Nuclear Imaging market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Provide global Advanced Molecular Nuclear Imaging market size and growth by region.
Chapter 7: Analyzes the main companies in the Advanced Molecular Nuclear Imaging industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 8: Analyzes the Advanced Molecular Nuclear Imaging Value Chain, including industrial chain and major downstream buyers.
Chapter 9: The main points and conclusions of the report.
Chapter 10: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey

Player list
Cardinal Health
Jubilant Pharma Holdings Inc.
Novartis AG
Siemens Healthcare GmbH
Koninklijke Philips N.V.
General Electric Company
Neusoft Corporation
Mediso Ltd.

Types list
SPECT Systems
Hybrid PET Systems
Planar Scintigraphy

Application list
Oncology
Cardiology
Neurology

Table of Content

1 Study Coverage
1.1 Advanced Molecular Nuclear Imaging Product Introduction
1.2 Global Advanced Molecular Nuclear Imaging Outlook 2019 VS 2024 VS 2030
1.3 United States Advanced Molecular Nuclear Imaging Outlook 2019 VS 2024 VS 2030
1.4 Advanced Molecular Nuclear Imaging Market Size, United States VS Global, 2019-2030
1.4.1 The Market Share of United States Advanced Molecular Nuclear Imaging in Global, 2019-2030
1.4.2 The Growth Rate of Advanced Molecular Nuclear Imaging Market Size, United States VS Global, 2019 VS 2024 VS 2030
1.5 Advanced Molecular Nuclear Imaging Market Dynamics
1.5.1 Advanced Molecular Nuclear Imaging Market Trends
1.5.2 Advanced Molecular Nuclear Imaging Market Drivers
1.5.3 Advanced Molecular Nuclear Imaging Market Challenges
1.5.4 Advanced Molecular Nuclear Imaging Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Advanced Molecular Nuclear Imaging Competitor Landscape by Company
2.1 Global Advanced Molecular Nuclear Imaging Market Size by Company
2.1.1 Top Global Advanced Molecular Nuclear Imaging Player Ranked by Revenue (2024)
2.1.2 Global Advanced Molecular Nuclear Imaging Revenue by Player (2019-2024)
2.2 Global Advanced Molecular Nuclear Imaging Concentration Ratio (CR)
2.2.1 Advanced Molecular Nuclear Imaging Market Concentration Ratio (CR) (2019-2024)
2.2.2 Global Top 3 and Top 6 Largest Players of Advanced Molecular Nuclear Imaging in 2024
2.3 Global Advanced Molecular Nuclear Imaging Business Distribution, Business Type
2.3.1 Global Advanced Molecular Nuclear Imaging Players, Headquarters and Distribution
2.3.2 Players Advanced Molecular Nuclear Imaging Business Type
2.3.3 Date of International Players Enter into Advanced Molecular Nuclear Imaging Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Advanced Molecular Nuclear Imaging Market Size by Company
2.5.1 Top United States Advanced Molecular Nuclear Imaging Player s Ranked by Revenue (2024)
2.5.2 United States Advanced Molecular Nuclear Imaging Revenue by Player (2019-2024)
3 Advanced Molecular Nuclear Imaging Market Segment by Type
3.1 Advanced Molecular Nuclear Imaging Market Segment by Type
3.2 Global Advanced Molecular Nuclear Imaging Market Size by Type
3.3 United States Advanced Molecular Nuclear Imaging Market Size by Type
4 Advanced Molecular Nuclear Imaging by Market Segment Application
4.1 Advanced Molecular Nuclear Imaging Market Segment by Application
4.2 Global Advanced Molecular Nuclear Imaging Market Size by Application
4.3 United States Advanced Molecular Nuclear Imaging Market Size by Application
5 Global Advanced Molecular Nuclear Imaging Market Size by Region
5.1 Global Advanced Molecular Nuclear Imaging Market Size by Region: 2019 VS 2024 VS 2030
5.2 Global Advanced Molecular Nuclear Imaging Market Size in Value by Region (2019-2030)
5.2.1 Global Advanced Molecular Nuclear Imaging Revenue by Region: 2019-2024
5.2.2 Global Advanced Molecular Nuclear Imaging Revenue by Region: 2024-2030
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Advanced Molecular Nuclear Imaging Market Size YoY Growth 2019-2030
6.1.2 North America Advanced Molecular Nuclear Imaging Market Facts & Figures by Country (2019-2030)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Advanced Molecular Nuclear Imaging Market Size YoY Growth 2019-2030
6.2.2 Asia Pacific Advanced Molecular Nuclear Imaging Market Facts & Figures by Country (2019-2030)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Advanced Molecular Nuclear Imaging Market Size YoY Growth 2019-2030
6.3.2 Europe Advanced Molecular Nuclear Imaging Market Facts & Figures by Country (2019-2030)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Advanced Molecular Nuclear Imaging Market Size YoY Growth 2019-2030
6.4.2 Latin America Advanced Molecular Nuclear Imaging Market Facts & Figures by Country (2019-2030)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Advanced Molecular Nuclear Imaging Market Size YoY Growth 2019-2030
6.5.2 Middle East and Africa Advanced Molecular Nuclear Imaging Market Facts & Figures by Country (2019-2030)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Cardinal Health
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 Advanced Molecular Nuclear Imaging Introduction
7.1.4 Cardinal Health Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024)
7.1.5 Cardinal Health Recent Development
7.2 Jubilant Pharma Holdings Inc.
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 Advanced Molecular Nuclear Imaging Introduction
7.2.4 Jubilant Pharma Holdings Inc. Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024)
7.2.5 Jubilant Pharma Holdings Inc. Recent Development
7.3 Novartis AG
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 Advanced Molecular Nuclear Imaging Introduction
7.3.4 Novartis AG Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024)
7.3.5 Novartis AG Recent Development
7.4 Siemens Healthcare GmbH
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 Advanced Molecular Nuclear Imaging Introduction
7.4.4 Siemens Healthcare GmbH Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024)
7.4.5 Siemens Healthcare GmbH Recent Development
7.5 Koninklijke Philips N.V.
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 Advanced Molecular Nuclear Imaging Introduction
7.5.4 Koninklijke Philips N.V. Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024)
7.5.5 Koninklijke Philips N.V. Recent Development
7.6 General Electric Company
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 Advanced Molecular Nuclear Imaging Introduction
7.6.4 General Electric Company Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024)
7.6.5 General Electric Company Recent Development
7.7 Neusoft Corporation
7.7.1 Company Details
7.7.2 Description and Business Overview
7.7.3 Advanced Molecular Nuclear Imaging Introduction
7.7.4 Neusoft Corporation Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024)
7.7.5 Neusoft Corporation Recent Development
7.8 Mediso Ltd.
7.8.1 Company Details
7.8.2 Description and Business Overview
7.8.3 Advanced Molecular Nuclear Imaging Introduction
7.8.4 Mediso Ltd. Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024)
7.8.5 Mediso Ltd. Recent Development
8 Value Chain and Sales Channels Analysis
8.1 Advanced Molecular Nuclear Imaging Value Chain Analysis
8.2 Advanced Molecular Nuclear Imaging Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer

List of Tables and Figures

Figure Advanced Molecular Nuclear Imaging Product Picture
Table Global Advanced Molecular Nuclear Imaging Revenue, ($), 2019 VS 2024 VS 2030
Figure Global Advanced Molecular Nuclear Imaging Market Size 2019-2030 ($)
Table United States Advanced Molecular Nuclear Imaging Revenue, ($), 2019 VS 2024 VS 2030
Figure United States Advanced Molecular Nuclear Imaging Market Size 2019-2030 ($)
Figure United States Advanced Molecular Nuclear Imaging Market Share in Global, in Value 2019-2030
Table Advanced Molecular Nuclear Imaging CAGR in Value, United States VS Global, 2019 VS 2024 VS 2030
Table Advanced Molecular Nuclear Imaging Market Trends
Table Advanced Molecular Nuclear Imaging Market Drivers
Table Advanced Molecular Nuclear Imaging Market Challenges
Table Advanced Molecular Nuclear Imaging Market Restraints
Figure Advanced Molecular Nuclear Imaging Report Years Considered
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Top Advanced Molecular Nuclear Imaging Players in Global Market, Ranking by Revenue (2024)
Table Global Advanced Molecular Nuclear Imaging Revenue by Player, ($), 2019-2024
Table Global Advanced Molecular Nuclear Imaging Revenue Share by Player, 2019-2024
Table Global Advanced Molecular Nuclear Imaging Players Market Concentration Ratio (CR5)
Figure The Top 3 and 6 Largest Players of Advanced Molecular Nuclear Imaging in the World: Market Share by Advanced Molecular Nuclear Imaging Revenue in 2024
Table Top Players of Advanced Molecular Nuclear Imaging in Global Market, Headquarters and Distribution
Table Players Advanced Molecular Nuclear Imaging Business Type
Table Date of International Players Enter into Advanced Molecular Nuclear Imaging Market
Table Players Mergers & Acquisitions, Expansion Plans
Table Top Advanced Molecular Nuclear Imaging Players in United States Market, Ranking by Revenue (2024)
Table United States Advanced Molecular Nuclear Imaging Revenue by Player, ($), 2019-2024
Table United States Advanced Molecular Nuclear Imaging Revenue Share by Player, 2019-2024
Table Global Advanced Molecular Nuclear Imaging Revenue by Type: 2024 VS 2030 ($)
Figure Global Advanced Molecular Nuclear Imaging Market Share by Type in 2024 & 2030
Figure Global Advanced Molecular Nuclear Imaging Revenue by Type (2019-2030) & ($)
Figure Global Advanced Molecular Nuclear Imaging Revenue Market Share in Value by Type (2019-2030)
Table United States Advanced Molecular Nuclear Imaging Revenue by Type: 2024 VS 2030 ($)
Figure United States Advanced Molecular Nuclear Imaging Market Share by Type in 2024 & 2030
Figure United States Advanced Molecular Nuclear Imaging Revenue by Type (2019-2030) & ($)
Figure United States Advanced Molecular Nuclear Imaging Revenue Market Share in Value by Type (2019-2030)
Table Global Advanced Molecular Nuclear Imaging Revenue by Application: 2024 VS 2030 ($)
Figure Global Advanced Molecular Nuclear Imaging Market Share by Application in 2024 & 2030
Figure Global Advanced Molecular Nuclear Imaging Revenue by Application (2019-2030) & ($)
Figure Global Advanced Molecular Nuclear Imaging Revenue Market Share in Value by Application (2019-2030)
Table United States Advanced Molecular Nuclear Imaging Revenue by Application: 2024 VS 2030 ($)
Figure United States Advanced Molecular Nuclear Imaging Market Share by Application in 2024 & 2030
Figure United States Advanced Molecular Nuclear Imaging Revenue by Application (2019-2030) & ($)
Figure United States Advanced Molecular Nuclear Imaging Revenue Market Share in Value by Application (2019-2030)
Table Global Advanced Molecular Nuclear Imaging Market Size by Region ($): 2019 VS 2024 VS 2030
Figure Global Advanced Molecular Nuclear Imaging Market Size Market Share by Region: 2019 VS 2024 VS 2030
Table Global Advanced Molecular Nuclear Imaging Revenue by Region (2019-2024) & ($)
Table Global Advanced Molecular Nuclear Imaging Revenue Forecast by Region (2024-2030) & ($)
Table Global Advanced Molecular Nuclear Imaging Revenue Market Share by Region (2019-2030)
Figure North America Advanced Molecular Nuclear Imaging Revenue Growth Rate 2019-2030
Table North America Advanced Molecular Nuclear Imaging Revenue by Country (2019-2030) & ($)
Figure U.S. Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Canada Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Asia Pacific Advanced Molecular Nuclear Imaging Revenue Growth Rate 2019-2030 ($)
Table Asia Pacific Advanced Molecular Nuclear Imaging Revenue by Country (2019-2030) & ($)
Figure China Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Japan Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure South Korea Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure India Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Australia Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Southeast Asia Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Europe Advanced Molecular Nuclear Imaging Revenue Growth Rate 2019-2030 ($)
Table Europe Advanced Molecular Nuclear Imaging Revenue by Country (2019-2030) & ($)
Figure Germany Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure France Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure UK Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Italy Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Russia Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Latin America Advanced Molecular Nuclear Imaging Revenue Growth Rate 2019-2030 ($)
Table Latin America Advanced Molecular Nuclear Imaging Revenue by Country (2019-2030) & ($)
Figure Mexico Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Brazil Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Argentina Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Middle East and Africa Advanced Molecular Nuclear Imaging Revenue Growth Rate 2019-2030 ($)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Revenue by Country (2019-2030) & ($)
Figure Turkey Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure Saudi Arabia Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Figure UAE Advanced Molecular Nuclear Imaging Revenue Growth Rate (2019-2030) & ($)
Table Cardinal Health Company Details
Table Description and Business Overview
Table Advanced Molecular Nuclear Imaging Introduction
Table Cardinal Health Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Cardinal Health Recent Development
Table Jubilant Pharma Holdings Inc. Company Details
Table Description and Business Overview
Table Advanced Molecular Nuclear Imaging Introduction
Table Jubilant Pharma Holdings Inc. Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Jubilant Pharma Holdings Inc. Recent Development
Table Novartis AG Company Details
Table Description and Business Overview
Table Advanced Molecular Nuclear Imaging Introduction
Table Novartis AG Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Novartis AG Recent Development
Table Siemens Healthcare GmbH Company Details
Table Description and Business Overview
Table Advanced Molecular Nuclear Imaging Introduction
Table Siemens Healthcare GmbH Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Siemens Healthcare GmbH Recent Development
Table Koninklijke Philips N.V. Company Details
Table Description and Business Overview
Table Advanced Molecular Nuclear Imaging Introduction
Table Koninklijke Philips N.V. Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Koninklijke Philips N.V. Recent Development
Table General Electric Company Company Details
Table Description and Business Overview
Table Advanced Molecular Nuclear Imaging Introduction
Table General Electric Company Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table General Electric Company Recent Development
Table Neusoft Corporation Company Details
Table Description and Business Overview
Table Advanced Molecular Nuclear Imaging Introduction
Table Neusoft Corporation Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Neusoft Corporation Recent Development
Table Mediso Ltd. Company Details
Table Description and Business Overview
Table Advanced Molecular Nuclear Imaging Introduction
Table Mediso Ltd. Advanced Molecular Nuclear Imaging Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Mediso Ltd. Recent Development
Figure Advanced Molecular Nuclear Imaging Value Chain
Table Major Customers of Advanced Molecular Nuclear Imaging with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report